Anatomical Therapeutic Chemical • L04AA • Selective immunosuppressants

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants

L04A Immunosuppressants

L04AA Selective immunosuppressants

L04AA01 cyclosporine

L04AA03 anti-lymphocyte immunoglobulin (horse)

L04AA03 human anti-lymphocyte immunoglobulin

L04AA04 anti-lymphocyte immunoglobulin

L04AA04 anti-lymphocyte immunoglobulin (rabbit)

L04AA04 rabbit anti-human lymphocyte immunoglobulin

L04AA06 mycophenolate

L04AA06 mycophenolate mofetil

L04AA08 daclizumab

L04AA10 sirolimus

L04AA13 leflunomide

L04AA17 adalimumab

L04AA21 efalizumab

L04AA23 natalizumab

L04AA24 abatacept

L04AA26 belimumab

L04AA28 belatacept

L04AA31 teriflunomide

L04AA32 apremilast

L04AA33 vedolizumab

L04AA34 alemtuzumab

L04AA40 cladribine

L04AA43 ravulizumab

L04AA50 ponesimod

L04AA58 efgartigimod alfa

L04AA60 remibrutinib

L04AB Tumor necrosis factor alpha (tnf-alpha) inhibitors

L04AC Interleukin inhibitors

L04AD Calcineurin inhibitors

L04AE Sphingosine-1-phosphate (S1P) receptor modulators

L04AF Janus-associated kinase (JAK) inhibitors

L04AG Monoclonal antibodies

L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors

L04AJ Complement inhibitors

L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors

L04AL Neonatal fragment crystallizable receptor (fcrn) inhibitors

L04AX Other immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various